Listen Score
LS 29
Global Rank
TOP 10%

SOBRE ESTE PODCAST 🔗

Frequência de atualização:
every 10 days
Duração média do áudio:
74 minutes
Entrevistas com convidados
Inglês
Estados Unidos da América
31 episódios
desde 18 de Novembro de 2025
episodic

ÚLTIMO EPISÓDIO 🔗

Producing the 3 to 5 grams of a biologic needed for IND-enabling studies costs millions of dollars using traditional CHO manufacturing. A single egg, meanwhile, contains 6 grams of protein, costs just 10 cents, and requires only chicken feed and water as inputs. Neion Bio is taking advantage of thi…

PESQUISAR EPISÓDIOS PASSADOS

Pesquisar episódios anteriores de Free Radicals.

EPISÓDIOS ANTERIORES

Twenty years ago, Dr. Derya Unutmaz predicted we would reverse aging by 2045. People thought he was crazy. Now, he thinks he was too conservative, and has moved the date up to 2040 because AGI arrived earlier than he expected. I sat down with Derya to ask if such bold predictions are too fatalistic…
Health podcasts are probably shortening your life expectancy. Not just because of the health anxiety they create, but because that time could instead be spent writing a letter to your congressperson. Aging kills 85% of Americans, and the US spends $15-20 per person per year on cancer research but o…
Reprogramming molecules are getting dosed into patients for the first time, with the goal of restoring function lost due to aging. I‘ve had over 30 recorded conversations about the longevity space and didn’t realize this is happening so soon! We sat down with Dr. Jamie Justice, the geroscientist ru…
AI is accelerating the pace of progress for benevolent scientists and nefarious actors alike. We discuss how DARPA is preparing to defend agriculture & civilians from novel biological threats, and why such defense requires training foundation models for biology. We also dive into why DARPA is b…
Kris Borer is an entrepreneur, angel investor, and author of the new book Radical Life Extension. We discuss why Kris rejects incrementalist approaches to radical life extension, and his argument that supplement, lifestyle interventions and small-molecule "geroscience" drugs offer only mi…
Jonathan Anomaly is a co-founder of Herasight and former PPE professor. Herasight is pioneering polygenic screening for embryos, to help parents undergoing IVF select embryos for health, intelligence, height, and other traits people care about. We discuss the ethics of embryo selection and radical …
Twelve months ago, we didn’t have working antibody design models. Now we have models that can compress 18 month design timelines down to one month, and agents that can collapse weeks of work by expert protein designers to an afternoon. This is an exciting time. Simon Kohl is a former Google DeepMin…
Elliot Hershberg is a partner at Amplify Partners and author of the popular blog Century of Biology. In this episode, we talk about GLP-1s as a breakthrough moment for biotech, why drug development is starting to behave like software, and how falling discovery costs could finally free biotech start…
Dr. James Peyer is founder and CEO of Cambrian Bio. James has spent two decades working to bring the first longevity drug to market. In this time, he’s brought over $500M into the field as a whole, and now has multiple drugs in clinical trials that could plausibly prove to be… the first true longev…
Aviso: O podcast e a arte incorporada nesta página são de Daniel Shur and Eric Dai, que é propriedade de seu proprietário e não é afiliado ou endossado por Listen Notes, Inc.